Extended interaction networks with HCV protease NS3-4A substrates explain the lack of adaptive capability against protease inhibitors

Inhibitors against the NS3-4A protease of hepatitis C virus (HCV) have proven to be useful drugs in the treatment of HCV infection. Although variants have been identified with mutations that confer resistance to these inhibitors, the mutations do not restore replicative fitness and no secondary muta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Biol Chem
Main Authors: Dultz, Georg, Shimakami, Tetsuro, Schneider, Markus, Murai, Kazuhisa, Yamane, Daisuke, Marion, Antoine, Zeitler, Tobias M., Stross, Claudia, Grimm, Christian, Richter, Rebecca M., Bäumer, Katrin, Yi, MinKyung, Biondi, Ricardo M., Zeuzem, Stefan, Tampé, Robert, Antes, Iris, Lange, Christian M., Welsch, Christoph
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Biochemistry and Molecular Biology 2020
Assuntos:
Microbiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535904/
https://ncbi.nlm.nih.gov/pubmed/32747444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.RA120.013898
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados